logo
Can Nippon Paint Tap Into India's PPF Market

Can Nippon Paint Tap Into India's PPF Market

Entrepreneur5 days ago
The paint protection films(PPF), launched by Nippon Paints, will be available across India and is expected to be present in more than 100 cities by the end of this year
Opinions expressed by Entrepreneur contributors are their own.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
The paint protection films(PPF) market in India is a burgeoning industry. The automotive sector accounts for a significant share of the paint protection film market. PPF is highly used to protect vehicles from road debris, scratches, etc and a rapidly expanding automotive industry is expected to boost its demand. With an eye on developing and expanding the market in India, Nippon Paints, under the n-SHIELD brand, has launched its own PPF.
"Our films cover all categories in the market, not just the premium. We plan to ultimately manufacture these products in India, in line with our Make in India philosophy, mirroring the government's efforts to bring international manufacturing to India," said Sharad Malhotra, director of Nippon Paint India.
PPF is a thermoplastic polyurethane film that can be applied on the painted surfaces of a car to protect the paint from stone chips, reduce abrasions and wear and tear. The PPF market in India is expected to reach a projected revenue of US$ 31.9 million by 2030. From 2023 to 2030, a compound annual growth rate(CAGR) of 7.6 percent is expected in India, according to estimates by Horizon Grand View Research.
The company has set up basic concept plants at the moment to manufacture this product in India. The product caters to mass, premium and luxury segments and is priced between INR 65,000 to INR two lakh. Nippon Paint has multiple sites for developing these films. Currently the products being launched in India are sourced from Japan and China. The paint major is actively seeking to develop new partnerships in India for strategic manufacturing of the product.
"It's still at a concept stage because this is a new technology. The kind of investments, opportunities we see are still evolving. Conceptually we are aligned that this should be manufactured in India but in terms of plant designs, plant sizes, investment sizes it's still a work in progress. If the product takes off very well, we can start manufacturing in the next two to three years. It depends on the adoption rate," Malhotra added. The current investment is primarily R&D focused.
Nippon Paints has been developing the PPF for four years. It started the film business division in Japan way back in 2021. In the middle of COVID as a part of the strategic review in the business, the company decided to enter the film business. India is the largest automotive aftermarket business in Nippon Paint Group and is the second region where the brand promises grand entry with films. First PPF was launched in Thailand.
The PPF comes with a five, seven, ten years warranty and is found in gloss, matte and colored ranges. The company is yet to finalize its original equipment manufacturer (OEM) partners. The entire detailing range consists of tyre dressers, dashboard cleaners, fabric cleaners, etc. Nippon Paint is also launching a host of other films including the headlamp film for which it has already received OEM endorsements. "We want to be a one stop solution, the car dealership or the detailing centre doesn't have to look out to multiple vendors. Nippon is there to serve them as a single source. This is a time where actually a player like Nippon Paint can add a lot of value, set standards, establish benchmarks, create ecosystems for the entire industry to benefit," he added.
This product will be available across India and is expected to be present in more than 100 cities by the end of this year. Not only cars, these films will be available for two-wheelers, bikes and trains as well.
In India right now the market is only two percent to three percent for cars and is expected to reach four percent to five percent in the next couple of years, estimated Malhotra.
The paint protection films market is consolidated in nature. Some of the major players globally include 3M, Saint-Gobain, Avery Dennison Corporation, Eastman Chemical Company, XPEL, Inc., among others.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Option Care Health, Inc. (OPCH): A Bull Case Theory
Option Care Health, Inc. (OPCH): A Bull Case Theory

Yahoo

time20 minutes ago

  • Yahoo

Option Care Health, Inc. (OPCH): A Bull Case Theory

We came across a bullish thesis on Option Care Health, Inc. on Brian's Substack by Brian Flasker. In this article, we will summarize the bulls' thesis on OPCH. Option Care Health, Inc.'s share was trading at $29.35 as of July 31st. OPCH's trailing and forward P/E were 23.29 and 19.65, respectively according to Yahoo Finance. A home infusion nurse in full PPE gown delivering treatments to a patient in their own home. Option Care Health (OPCH) has evolved into the dominant independent provider of home and alternate site infusion services in the U.S., originating from Madison Dearborn Partners' 2015 acquisition of Walgreens Infusion Services. The 2019 reverse merger with BioScrip and full divestiture by Walgreens and MDP by 2023 paved the way for OPCH to operate with full independence. Led by CEO John Rademacher and CFO Michael Shapiro, both with substantial equity stakes, OPCH has built a national infrastructure of 91 pharmacies and 99 infusion suites, covering 96% of the U.S. population. The company's integrated model provides cost-effective, high-quality infusion therapies in outpatient and home settings, capitalizing on a healthcare trend shifting treatments away from costly hospitals. This platform serves over 1,400 contracts with 800+ partners, including all top 10 national insurers. Acute therapies, though operationally complex, act as a competitive wedge, while chronic therapies anchor long-term recurring revenues. OPCH's mix—75% chronic, 25% acute—combined with a focus on generics and biosimilars, ensures resilience against pricing volatility. With its Advanced Practitioner (AP) model, OPCH is pushing clinical boundaries, managing more complex therapies in lower-cost settings and enhancing utilization of its already-built infrastructure. Only ~50% of its infusion suite capacity is currently utilized, leaving ample runway for capital-light growth. Despite industry concerns like drug pricing reforms and labor shortages, OPCH's embedded relationships, clinical capabilities, and scalable model offer strong visibility into cash flow and earnings. Trading at ~15.4x 2025 owner earnings with a 17.4% expected IRR, OPCH represents a high-quality compounder with an entrenched moat and significant upside. Previously, we covered a bullish thesis on Chemed Corporation by 310 Value in April 2025, which highlighted the durability of its earnings, temporary volatility in its subsidiaries, and disciplined share repurchases. The company's stock price has depreciated by approximately 29% since our coverage. This is because temporary segment headwinds persisted longer than expected. The thesis still stands as Chemed's core fundamentals remain intact. Brian Flasker shares a similar view but emphasizes OPCH's capital-light model and payer-aligned infrastructure. Option Care Health, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 40 hedge fund portfolios held OPCH at the end of the first quarter, which was 40 in the previous quarter. While we acknowledge the potential of OPCH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

The Revision Economy And The Retraction Life
The Revision Economy And The Retraction Life

Forbes

time23 minutes ago

  • Forbes

The Revision Economy And The Retraction Life

Last Friday, we learned we are less employed than we thought we were. A quarter million jobs vanished, yet no one new was fired and no one new quit. Those jobs never existed in the first place. Only our estimate of the truth changed, not the truth itself. This was definitely a large revision. The two-month downward revision in jobs hadn't been this negative since Covid, and before that, the global financial crisis in October 2008. Before that, it hadn't happened in decades, with only a handful of occurrences in 1979, 1980, and 1982. In response, the US equity market fell between one and two percent and Treasury bond yields collapsed, especially in the front-end, as the market began pricing in a substantially higher expectation of Fed rate cuts. President Trump ordered the firing of the commissioner of the Bureau of Labor Statistics (BLS), citing 'a lengthy history of inaccuracies and incompetence.' Should he have? Revision History Usually, revisions are frequent and fairly modest. The monthly nonfarm payroll report is always revised twice, so there are three numbers: the preliminary estimate, the first revision the following month, and the second revision in the month following that. There are also annual revisions. The average magnitude of the revisions since 1979 are between 40,000 and 60,000 jobs. Sometimes we find out we are more employed than we thought we were, and sometimes less. On Friday, the May 2025 seasonally adjusted estimate was revised down 120,000 jobs from its first estimate and the June 2025 estimate was revised down 133,000 jobs. Each of those was historically extreme, worse than 95% of relevant monthly revisions since 1979. The two-month combination was basically a once-in-a-decade event, as the chart above shows. Big numbers. But ultimately, they are just one source of data. Jobs numbers help us think about the economy, but they are just one piece of the puzzle. What makes job numbers particularly useful is they may be forward-looking: rather than estimating historical consumer purchases, job creation can presage future spending. That's why revisions could matter too. You drive differently if you think your exit is three miles away than if you think it's a quarter mile away. But we can't live our lives in the past, constantly revising what we used to think about ancient history. So, when should a revision of the past change your perspective of the future? Estimates vs. Reality Surely, it should have some effect. One famous quote attributed to John Maynard Keynes summarizes this view: 'When the facts change, I change my mind. What do you do, sir?' Of course, not all facts matter the same amount or at the same time. Yesterday's future is tomorrow's past. Eventually, other data should matter more than the jobs numbers. If the BLS announced an inadvertent and unnoticed typo in a jobs number from eight years ago, that should presumably have almost no effect on your views today, since so much additional data has already come in, about spending, saving, production, consumption, inflation, and more. In other words, those quarter million jobs either existed or not. Estimates and revisions won't change what actually happened. Even knowing the exact true number is only a proxy for the actual information you would be interested in, and as time has gone on, other data has come out that can be more valuable and important than a more accurate but more historically distant estimate. There is a devastating counterpoint, however, as anyone who has ever been in any kind of personal or professional relationship would know. If a piece of information about the ancient past can change or color your perception of the entire relationship, then almost no amount of time can reduce that emotional impact. In any fight with a loved one, the biggest pain isn't whatever action they did or did not do, or your best estimate of their action, or even the revisions of your best estimates of their actions: it's the possibility that they never loved you at all. Was it all a lie? President Trump's firing of the BLS commissioner may be controversial. But both the administration and its critics worry about the same thing: data ought to be as accurate and objective as possible. This issue is a lot like reading the news. The loud front pages say one thing, usually preliminary news. Later retractions or corrections are quiet and unnoticed. As a society, we can begin to split and live in two different worlds: those that did not know the truth and did not see the retraction, and those that knew the truth or saw the retraction. Therefore, we no longer even have the same facts. Some of us begin to live in the hallucinated, unrevised, unretracted world, a world much like the Mandela effect, where we swear we remember things that in fact never happened. Trust is a fragile thing. A good-faith revision here or a revision there can be fine. But if you notice a consistent bias or pattern in the revisions and retractions, if the errors are rarely in your favor, you may stop subscribing to that source of news or data. If you are in a relationship, you may look to end or fix it. If you are the President of the United States, you may seek a new commissioner. The primary challenge in all these cases is then the same: restore the trust. In the revision economy and the retraction life, beliefs can bend, but faith can snap.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store